{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:33:15Z","timestamp":1793910795070,"version":"4.8.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T00:00:00Z","timestamp":1557446400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T00:00:00Z","timestamp":1557446400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1038\/s10038-019-0603-7","type":"journal-article","created":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T10:05:04Z","timestamp":1557482704000},"page":"741-755","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Newborn screening for Pompe disease in Japan: report and literature review of mutations in the GAA gene in Japanese and Asian patients"],"prefix":"10.1038","volume":"64","author":[{"given":"Ken","family":"Momosaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1328-6696","authenticated-orcid":false,"given":"Jun","family":"Kido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keishin","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuki","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahito","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshika","family":"Okumiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1986-0951","authenticated-orcid":false,"given":"Shirou","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumio","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimitoshi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,10]]},"reference":[{"key":"603_CR1","doi-asserted-by":"publisher","first-page":"9641","DOI":"10.1073\/pnas.83.24.9641","volume":"83","author":"F Martiniuk","year":"1986","unstructured":"Martiniuk F, Mehler M, Pellicer A, Tzall S, La Badie G, Hobart C, et al. Isolation of a cDNA for human acid \u03b1-glucosidase and detection of genetic heterogeneity for mRNA in three \u03b1-glucosidase deficient patients. Proc Natl Acad Sci USA. 1986;83:9641\u20134.","journal-title":"Proc Natl Acad Sci USA"},{"key":"603_CR2","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1212\/01.WNL.0000165979.46537.56","volume":"64","author":"MLC Hagemans","year":"2005","unstructured":"Hagemans MLC, Winkel LPF, Hop WCJ, Reuser AJJ, Van Doorn PA, Van der Ploeg AT. Disease severity in children and adults with Pompe disease related to age and disease duration. Neurology. 2005;64:2139\u201341.","journal-title":"Neurology"},{"key":"603_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","volume":"68","author":"PS Kishnani","year":"2007","unstructured":"Kishnani PS, Corzo D, Nicolino M, Byrne B, Mandel H, Hwu WL, et al. Recombinant human acid alpha-glucosidase: major clinical benefits in infantile-onset Pompe disease. Neurology. 2007;68:99\u2013109.","journal-title":"Neurology"},{"key":"603_CR4","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","volume":"15","author":"AT Van der Ploeg","year":"2010","unstructured":"Van der Ploeg AT, Clemens PR, Corzo D, Escolar DM, Florence J, Groeneveld G, et al. A randomized study of alglucosidase alfa in late-onset Pompe's disease. N Engl J Med. 2010;15:1396\u2013406.","journal-title":"N Engl J Med"},{"key":"603_CR5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1203\/PDR.0b013e3181b24e94","volume":"66","author":"PS Kishnani","year":"2009","unstructured":"Kishnani PS, Corzo D, Leslie ND, Gruskin D, Van der Ploeg A, Clancy JP, et al. Early treatment with alglucosidase alpha prolongs long-term survival of infants with Pompe disease. Pedia Res. 2009;66:329\u201335.","journal-title":"Pedia Res"},{"key":"603_CR6","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/gim.2012.44","volume":"14","author":"SN Prater","year":"2012","unstructured":"Prater SN, Banugaria SG, DeArmey SM, Botha EG, Stege EM, Case LE, et al. The emerging phenotype of long-term survivors with infantile Pompe disease. Genet Med. 2012;14:800\u201310.","journal-title":"Genet Med"},{"key":"603_CR7","doi-asserted-by":"publisher","first-page":"e1116","DOI":"10.1542\/peds.2008-3667","volume":"124","author":"YH Chien","year":"2009","unstructured":"Chien Y-H, Lee N-C, Thurberg BL, Chiang S-C, Zhang XK, Keutzer J, et al. Pompe Disease in Infants: improving the prognosis by newborn screening and early treatment. Pediatrics. 2009;124:e1116.","journal-title":"Pediatrics"},{"key":"603_CR8","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/ajmg.a.36197","volume":"164A","author":"CF Yang","year":"2014","unstructured":"Yang C-F, Liu H-C, Hsu T-R, Tsai F-C, Chiang S-F, Chiang C-C, et al. A large-scale nationwide newborn screening program for Pompe disease in Taiwan: towards effective diagnosis and treatment. Am J Med Genet A. 2014;164A:54\u201361.","journal-title":"Am J Med Genet A"},{"key":"603_CR9","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/ejhg.2008.34","volume":"16","author":"MA Kroos","year":"2008","unstructured":"Kroos MA, Mullaart RA, Van Vliet L, Pomponio RJ, Amartino H, Kolodny EH, et al. p.[G576S; E689K]: pathogenic combination or polymorphism in Pompe disease? Eur J Hum Genet. 2008;16:875\u20139.","journal-title":"Eur J Hum Genet"},{"key":"603_CR10","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ymgme.2009.03.004","volume":"97","author":"S Kumamoto","year":"2009","unstructured":"Kumamoto S, Katafuchi T, Nakamura K, Endo F, Oda E, Okuyama T, et al. High frequency of acid \u03b1-glucosidase pseudodeficiency complicates newborn screening for glycogen storage disease type II in the Japanese population. Mol Genet Metab. 2009;97:190\u20135.","journal-title":"Mol Genet Metab"},{"key":"603_CR11","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ymgme.2009.12.014","volume":"99","author":"P Labrousse","year":"2010","unstructured":"Labrousse P, Chien Y-H, Pomponio RJ, Keutzer J, Lee N-C, Akmaev VR, et al. Genetic heterozygosity and pseudodeficiency in the Pompe disease newborn screening pilot program. Mol Genet Metab. 2010;99:379\u201383.","journal-title":"Mol Genet Metab"},{"key":"603_CR12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ymgme.2011.01.006","volume":"103","author":"S Shigeto","year":"2011","unstructured":"Shigeto S, Katafuchi T, Okuda Y, Nakamura K, Endo F, Okuyama T, et al. Improved assay for differential diagnosis between Pompe disease and acid \u03b1-glucosidase pseudodeficiency on dried blood spots. Mol Genet Metab. 2011;103:12\u20137.","journal-title":"Mol Genet Metab"},{"key":"603_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/01.gim.0000218152.87434.f3","volume":"8","author":"PS Kishnani","year":"2006","unstructured":"Kishnani PS, Steiner RD, Bali D, Berger K, Byrne BJ, Case L, et al. Pompe disease diagnosis and management guideline. Genet Med. 2006;8:267\u201388.","journal-title":"Genet Med"},{"key":"603_CR14","first-page":"14","volume":"24","author":"S Yoshida","year":"2015","unstructured":"Yoshida S. Genetic testing of lysosomal storage diseases by next-generation sequencer. Sci Rep Chemo-Sero-Ther Res Inst. 2015;24:14\u201331. \n                    https:\/\/www.kaketsuken.org\/pdf\/003-reimei-24.pdf","journal-title":"Sci Rep Chemo-Sero-Ther Res Inst"},{"key":"603_CR15","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S0960-8966(00)00142-5","volume":"10","author":"S Tsujino","year":"2000","unstructured":"Tsujino S, Huie M, Kanazawa N, Sugie H, Goto Y, Kawai M, et al. Frequent mutations in Japanese patients with acid maltase deficiency. Neuromuscul Disord. 2000;10:599\u2013603.","journal-title":"Neuromuscul Disord"},{"key":"603_CR16","doi-asserted-by":"publisher","first-page":"D862","DOI":"10.1093\/nar\/gkv1222","volume":"44","author":"MJ Landrum","year":"2016","unstructured":"Landrum MJ, Lee JM, Benson M, Brown G, Chao C, Chitipiralla S, et al. ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res. 2016;44:D862\u2013D868.","journal-title":"Nucleic Acids Res"},{"key":"603_CR17","doi-asserted-by":"publisher","first-page":"7.20.1","DOI":"10.1002\/0471142905.hg0720s76","volume":"76","author":"I Adzhubei","year":"2013","unstructured":"Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet. 2013;76:7.20.1\u201341.","journal-title":"Curr Protoc Hum Genet"},{"key":"603_CR18","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1093\/nar\/gkp215","volume":"37","author":"FO Desmet","year":"2009","unstructured":"Desmet F-O, Hamroun D, Lalande M, Collod-Beroud G, Claustres M, Beroud C. Human splicing finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 2009;37:e67.","journal-title":"Nucleic Acids Res"},{"key":"603_CR19","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nmeth.2890","volume":"11","author":"JM Schwarz","year":"2014","unstructured":"Schwarz JM, Cooper DN, Schuelke M, Seelow D. MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods. 2014;11:361\u20132.","journal-title":"Nat Methods"},{"key":"603_CR20","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/dnares\/dsq010","volume":"17","author":"A Hijikata","year":"2010","unstructured":"Hijikata A, Raju R, Keerthikumar S, et al. Mutation@A Glance: an integrative Web application for analyzing mutations from human genetic diseases. DNA Res. 2010;17:197\u2013208.","journal-title":"DNA Res"},{"key":"603_CR21","first-page":"760","volume":"45","author":"JJ Qiu","year":"2007","unstructured":"Qiu J-J, Wei M, Zhang W-M, Shi H-P. Clinical and molecular genetic study on two patients of the juvenile form of Pompe disease in China. Chin J Pedia. 2007;45:760\u20134.","journal-title":"Chin J Pedia"},{"key":"603_CR22","unstructured":"Eto Y ed. Pompe disease (glycogen storage disease type II) diagnosis and management guideline for Japanese (revised edition). (2013) (En Medix Co. Ltd, Tokyo, Japan)."},{"key":"603_CR23","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1017\/cjn.2016.37","volume":"43","author":"M Tarnopolsky","year":"2016","unstructured":"Tarnopolsky M, Katzberg H, Petrof BJ, Sirrs S, Sarnat HB, Myers K, et al. Pompe disease: diagnosis and management. Evidence-based guidelines from a Canadian expert panel. Can J Neurol Sci. 2016;43:472\u201385.","journal-title":"Can J Neurol Sci"},{"key":"603_CR24","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1542\/peds.2016-0280C","volume":"140","author":"OA Bodamer","year":"2017","unstructured":"Bodamer OA, Scott R, Giugliani R. Newborn screening for Pompe disease. Pediatrics. 2017;140:S4\u201313.","journal-title":"Pediatrics"},{"key":"603_CR25","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/sj.ejhg.5200367","volume":"7","author":"MGEM Ausems","year":"1999","unstructured":"Ausems MGEM, Verbiest J, Hermans MMP, Kroos MA, Beemer FA, Wokke JHJ, et al. Frequency of glycogen storage disease type II in the Netherlands: implications for diagnosis and genetic counseling. Eur J Hum Genet. 1999;7:713\u20136.","journal-title":"Eur J Hum Genet"},{"key":"603_CR26","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1086\/301788","volume":"62","author":"JA Becker","year":"1998","unstructured":"Becker JA, Vlach J, Raben N, Nagaraju K, Adams EM, Hermans MM, et al. The African origin of the common mutation in African American patients with glycogen-storage disease type II. Am J Hum Genet. 1998;62:991\u20134.","journal-title":"Am J Hum Genet"},{"key":"603_CR27","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1093\/hmg\/3.7.1081","volume":"3","author":"ML Huie","year":"1994","unstructured":"Huie ML, Chen AS, Tsujino S, Shanske S, DiMauro S, Engel AG, et al. Aberrant splicing in adult-onset glycogen storage disease type II (GSDII): molecular identification of an IVS1 (-13T->G) mutation in a majority of patients and a novel IVS10 (+1GT->CT) mutation. Hum Mol Genet. 1994;3:2231\u20136.","journal-title":"Hum Mol Genet"},{"key":"603_CR28","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.nmd.2011.11.003","volume":"22","author":"RS Tsuburaya","year":"2012","unstructured":"Tsuburaya RS, Monma K, Oya Y, Nakayama T, Fukuda T, Sugie H, et al. Acid phosphatase-positive globular inclusions is a good diagnostic marker for two patients with adult-onset Pompe disease lacking disease-specific pathology. Neuromuscul Disord. 2012;22:389\u201393.","journal-title":"Neuromuscul Disord"},{"key":"603_CR29","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/(SICI)1098-1004(1998)11:4<306::AID-HUMU8>3.0.CO;2-S","volume":"11","author":"JJ Shieh","year":"1998","unstructured":"Shieh J-J, Lin C-Y. Frequent mutation of Chinese patients with infantile type of GSD II in Taiwan: evidence for a founder effect. Hum Mutat. 1998;11:306\u201312.","journal-title":"Hum Mutat"},{"key":"603_CR30","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s00415-008-0714-0","volume":"255","author":"L Wan","year":"2008","unstructured":"Wan L, Lee C-C, Hsu C-M, Hwu W-L, Yang C-C, Tsai C-H, Tsai F-J. Identification of eight novel mutations of the acid \u03b1-glucosidase gene causing the infantile or juvenile form of glycogen storage disease type II. J Neurol. 2008;255:831\u20138.","journal-title":"J Neurol"},{"key":"603_CR31","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ymgmr.2016.08.007","volume":"9","author":"R Mashima","year":"2016","unstructured":"Mashima R, Sakai E, Kosuga M, Okuyama T. Levels of enzyme activities in six lysosomal storage diseases in Japanese neonates determined by liquid chromatography-tandem mass spectrometry. Mol Genet Metab Rep. 2016;9:6\u201311.","journal-title":"Mol Genet Metab Rep"},{"key":"603_CR32","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1373\/clinchem.2016.259036","volume":"63","author":"N Lin","year":"2017","unstructured":"Lin N, Huang J, Violante S, Orsini JJ, Caggana M, Hughes EE, et al. Liquid chromatography-tandem mass spectrometry assay of leukocyte acid \u03b1-glucosidase for post-newborn screening evaluation of Pompe disease. Clin Chem. 2017;63:842\u201351.","journal-title":"Clin Chem"}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s10038-019-0603-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s10038-019-0603-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s10038-019-0603-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:07:22Z","timestamp":1684616842000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s10038-019-0603-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,10]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["603"],"URL":"https:\/\/doi.org\/10.1038\/s10038-019-0603-7","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,10]]},"assertion":[{"value":"15 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study was approved by the Ethics Committee of Kumamoto University (approval no. 1537). Written informed consent was obtained from the parents or legal guardians of newborns.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}